8-MOP

LOE Approaching

methoxsalen

NDAORALCAPSULEPriority Review
Approved
Dec 1954
Lifecycle
LOE Approaching
Competitive Pressure
30/100

Mechanism of Action

II. CLINICAL PHARMACOLOGY The combination treatment regimen of psoralen (P) and ultraviolet radiation of 320-400 nm wavelength commonly referred to as UVA is known by the acronym, PUVA. Skin reactivity to UVA (320–400 nm) radiation is markedly enhanced by the ingestion of methoxsalen. In a well…

Indications (1)